Satellos Bioscience Inc (LSX:A4211W) Financings

Satellos Bioscience Inc

Financings

RaiseDateIn US dollars
Public offering of common shares and pre-funded warrants
Closed: US$57.2M raised · US$10.1 a share · Leerink Partners +4
Dealers: Leerink Partners (co-lead), Guggenheim Securities (co-lead), Oppenheimer & Co. (co-lead), Bloom Burton, Bloom Burton Securities Inc.
Buyers: Franklin Berger (24,750 common shares); Mark Nawacki (30,000 common shares)
Insiders: Director Franklin Berger purchased 24,750 common shares; no other insiders participated.
Use of proceeds: Research and development including SAT-3247 clinical trials, other discovery and pre-clinical programs, working capital and general corporate purposes
Feb 9, 2026
Warrant exercise of share purchase warrants
Closed: C$1.04M raised
Sep 22, 2025US$754,560

Read by 6ix AI from the company's releases